Charles River Laboratories International (CRL) Net Margin (2009 - 2025)

Charles River Laboratories International (CRL) has reported Net Margin for 16 consecutive years, with 27.82% the latest figure, recorded in Q4 2025.

• In Q4 2025, Net Margin fell 630.0% year-over-year to 27.82%; the TTM figure through Dec 2025 stood at 3.59% (down 385.0% YoY), while the FY2025 annual figure was 3.59%, down 385.0% from the prior year.
• Net Margin came in at 27.82% for Q4 2025 at Charles River Laboratories International, down from 5.42% in the prior quarter.
• The five-year high for Net Margin was 18.46% in Q4 2023, with the low at 27.82% in Q4 2025.
• Average Net Margin over 5 years is 6.29%, with a median of 8.96% recorded in 2023.
• Across the five-year window, Net Margin surged 267 bps in 2022 and sank 3997 bps in 2024, its largest moves.
• Year by year, Net Margin stood at 15.45% in 2021, then gained by 11 bps to 17.19% in 2022, then climbed by 7 bps to 18.46% in 2023, then slumped by 217 bps to 21.52% in 2024, then declined by 29 bps to 27.82% in 2025.
• According to Business Quant data, Net Margin over the past three periods registered 27.82%, 5.42%, and 5.07% for Q4 2025, Q3 2025, and Q2 2025 respectively.